DOCSLIB.ORG

China Qinba Pharmaceuticals, Inc

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
China Qinba Pharmaceuticals, Inc CHINA QINBA PHARMACEUTICALS, INC. FORM S-1/A (Securities Registration Statement) Filed 07/31/09 Telephone 917-596-9881 CIK 0001452777 SIC Code 2834 - Pharmaceutical Preparations Fiscal Year 12/31 http://access.edgar-online.com © Copyright 2010, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use. As filed with the United States Securities and Exchange Commission on July 31, 2009 Registration No. 333-156543 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA QINBA PHARMACEUTICALS, INC. (Name of small business issuer in its charter) Delaware 0-51477 33-1218037 (State or other jurisdiction of (primary standard industrial (I.R.S. Employer incorporation or organization) classification code number) Identification No.) 24 th Floor, Building A Zhengxin Mansion, No. 5 of 1 st Gaoxin Road Hi-Tech Development Zone Xi’an City People’s Republic of China 029-82098912-8038 (Address and telephone number of principal executive offices and principal place of business) Chen Xi Huang Wong 21112 64 th Avenue Oakland Gardens, New York 11364 (917) 596-9881 (Name, address and telephone number of agent for service) __________ Copies to: Hank Gracin, Esq. Lehman & Eilen LLP Mission Bay Office Plaza Suite 300 20283 State Road 7 Boca Raton, FL 33498 Tel: (561) 237-0804 Fax: (561) 237-0803 Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier registration statement for the same offering. If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large Accelerated Filer Accelerated Filer Non-Accelerated Filer Smaller Reporting Company If the delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. Proposed Proposed Title Of Each Maximum Maximum Class of Securities Amount To Offering Price Aggregate Amount of To be Registered Be Registered(1) Per Share(2) Offering Price Registration Fee(3) Common stock, par value $0.0001 per share 1,000,000(4) $3.50 $3,500,000 $137.55 Total 1,000,000(4) $3,500,000 $137.55 ——————— (1) In accordance with Rule 416(a), the registrant is also registering hereunder an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. (2) Estimated in accordance with Rule 457 of the Securities Act of 1933 solely for the purpose of computing the amount of the registration fee based on the recent sales of unregistered securities. The common stock is presently not traded on any market and the Registrant makes no representation as to the price at which its common stock may trade. (3) The registration fee is calculated based on $39.30 per $1,000,000. Previously paid. (4) Represents shares of the registrant’s common stock being registered for resale that have been issued or may be issued to the selling stockholders named in this registration statement. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the United States Securities and Exchange Commission, acting pursuant to said section 8(a), may determine. The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the United States Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any state where the offer or sale is not permitted. SUBJECT TO COMPLETION, DATED JULY 31, 2009 PRELIMINARY PROSPECTUS CHINA QINBA PHARMACEUTICALS, INC. 1,000,000 shares of common stock This prospectus relates to the resale of up to 1,000,000 shares of our common stock, $0.0001 par value per share, by certain of our stockholders. These persons, together with their transferees, are referred to throughout this prospectus as “selling stockholders.” We issued all of the shares described above in private placement transactions completed prior to the filing of this registration statement. We are not selling any shares of our common stock in this offering and therefore will not receive any proceeds from this offering. Instead, the shares may be offered and sold from time to time by the selling stockholders and/or their registered representatives at a fixed price of $3.50 until such shares are quoted, if ever, on the OTC Bulletin Board or another exchange or electronic medium and thereafter at prevailing market prices or privately negotiated prices. As a result of such activities, the selling stockholders may be deemed to be underwriters as that term is defined in the federal securities laws. Our common stock does not presently trade on any exchange or electronic medium. We intend to apply to have our common stock listed on the OTC Bulletin Board once this prospectus is declared effective. However, no assurance can be given that our common stock will trade on the OTC Bulletin Board or any other exchange or electronic medium. You should consider carefully the risk factors beginning on page 4 of this prospectus. Neither the United States Securities and Exchange Commission nor any state securities commission has approved of these securities or determined that this prospectus is accurate or complete. Any representation to the contrary is a criminal offense. The date of this prospectus is July _____, 2009 TABLE OF CONTENTS Page Number Prospectus Summary 1 Risk Factors 4 Use Of Proceeds 19 Market For Common Equity And Related Stockholder Matters 19 Determination Of Market Price 19 Securities Authorized For Issuance Under Equity Compensation Plans 19 Management ’s Discussion And Analysis (MD&A) Of Financial Condition And Results Of Operations 20 Forward -Looking Statements 20 Contractual Obligations 25 Our Business 27 Directors And Executive Officers 42 Litigation 42 Certain Relationships And Related Party Transactions 43 Executive Compensation 44 Security Ownership Of Certain Beneficial Owners And Management 46 Selling Stockholders 47 Plan Of Distribution 48 Description Of Securities 50 Experts 50 Legal Matters 51 Indemnification Of Directors And Officers 51 Changes In And Disagreements With Accountants 51 Where You Can Find More I nformation 51 i ABOUT THIS PROSPECTUS You should rely only on the information contained in the prospectus. We have not authorized anyone to provide you with information or to make any representations about us, the selling stockholders, the securities or any matter discussed in this prospectus, other than that contained in the prospectus. If any other information or representation is given or made, such information or representations may not be relied upon as having been authorized by us or any selling stockholder. The selling stockholders are offering to sell and seeking offers to buy shares of our common stock only in jurisdictions where offers and sales are permitted. This prospectus does not constitute an offer to sell, or a solicitation of an offer to buy the securities in any circumstances under which the offer or solicitation is unlawful. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Neither the delivery of this prospectus nor any distribution of securities in accordance with this prospectus shall, under any circumstances, imply that there has been no change in our affairs since the date of this prospectus. The prospectus will be updated and updated prospectuses made available for delivery to the extent required by the federal securities laws. .When used in this prospectus, the terms: • “China Qinba, ” the “Company, ” “ we, ” “ our ” and “us ” refers to China QinBa Pharmaceuticals, Inc., a Delaware corporation. • “Xi ’an Development ” refers to our wholly owned subsidiary Xi ’an Pharmaceuticals Development Co., Ltd., a limited liability company organized under the laws of the PRC. • “Xi’an Pharmaceuticals” refers to our variable interest entity (“VIE”), Xi’an Qinba Pharmaceuticals Co., Ltd., a company organized under the laws of the PRC that has entered into a series of agreements with Xi’an Development that (i) give Xi’an Development control over the board of directors, officers, operations and finances of Xi’an Pharmaceuticals; (ii) permit Xi’an Pharmaceuticals to be treated as a subsidiary of Xi’an Development under the laws of the People’s Republic of China; and (iii) allow us to consolidate its financial statements under GAAP.
Load more

Recommended publications
  • Integration of Grey with Neural Network Model and Its Application in Data Mining
    716 JOURNAL OF SOFTWARE, VOL. 6, NO. 4, APRIL 2011 Integration of Grey with Neural Network Model and Its Application in Data Mining Changjun Zhu College of Urban Construction, Hebei University of Engineering, Handan, 056038, China [email protected] Qinghua Luan College of Water Conservancy and Hydropower, Hebei University of Engineering, Handan, 056038, China Zhenchun Hao, Qin Ju State Key Laboratory of Hydrology-Water Resources and Hydraulic Engineering, Hohai University, Nanjing, China Abstract—Because of Boundary types and geologic which include advection, diffusion, dispersion, sorption, conditions, which possess random and obscure decay and biodegradation. In the courses，there is not characteristics, groundwater heads vary with the conditions. only the known information but also uncertain The prediction of groundwater level is one of the main work of hydraulic government, which is predicted based on the information, therefore, it can be seen as one gray system. history data and the relative influence factors. Therefore, Groundwater trends are related to atmosphere prediction precision depends on the accuracy of history precipitation. There is obvious seasonality variation of data. Data mining has provided a new method for analyzing atmosphere precipitation. Therefore, the groundwater massive, complex and noisy data. According to the level is changed by the seasons and periods. In this case, complexity and ambiguity of groundwater system, a new we needed to use the original data of the groundwater in integration of grey with neural network model is built to order to predict the groundwater level. In this paper, we forecast groundwater heads, which were used to judge calculated the cycle groundwater, trend groundwater, and whether future groundwater heads were extraordinarily random groundwater separately after isolating the three over the history range or not.
    [Show full text]
  • An Analysis of the Death Mystery of Huo Qubing, a Famous Cavalry General in the Western Han Dynasty
    Journal of Frontiers of Society, Science and Technology DOI: 10.23977/jfsst.2021.010410 Clausius Scientific Press, Canada Volume 1, Number 4, 2021 An Analysis of the Death Mystery of Huo Qubing, a Famous Cavalry General in the Western Han Dynasty Liu Jifeng, Chen Mingzhi Shandong Maritime Vocational College, Weifang, 261000, Shandong, China Keywords: Huo qubing, Myth, Mysterious death Abstract: Throughout his whole lifetime, Huo Qubing created a myth of ancient war, and left an indelible mark in history. But, pitifully, he suddenly died during young age. His whole life was very short, and it seemed that Huo was born for war and died at the end of war. Although he implemented his great words and aspirations “What could be applied to get married, since the Huns haven’t been eliminated?”, and had no regrets for life, still, his mysterious death caused endless questions and intriguing reveries for later generations. 1. Introduction Huo Qubing, with a humble origin, was born in 140 B.C. in a single-parent family in Pingyang, Hedong County, which belongs to Linfen City, Shanxi Province now. He was an illegitimate child of Wei Shaoer, a female slave of Princess Pingyang Mansion, and Huo Zhongru, an inferior official. Also, he was a nephew-in-mother of Wei Qing, who was General-in-chief Serving as Commander-in-chief in the Western Han Dynasty. Huo Qubing was greatly influenced by his uncle Wei Qing. He was a famous military strategist and national hero during the period of Emperor Wudi of the Western Han Dynasty. He was fond of horse-riding and archery.
    [Show full text]
  • List of 143 Chinese Invitees to the Nobel Peace Prize Award Ceremony
    Chinese Human Rights Defenders (CHRD) 维权网 Web: http://chrdnet.org/ Email: [email protected] Promoting human rights and empowering grassroots activism in China List of 143 Chinese invitees to the Nobel Peace Prize award ceremony As the restrictions facing these individuals is subject to rapid change in the days and hours before the Nobel Peace Prize award ceremony on December 10, please see our website, www.chrdnet.org, for the latest updates. 1. Ai Xiaoming (艾晓明), Guangzhou human rights activist and Sun Yat-sen University professor, under tight surveillance and restriction on movements 2. Bao Tong (鲍彤), former political secretary to CCP General Secretary Zhao Ziyang (赵 紫阳), under soft detention at home in Beijing 3. Cha Jianguo (查建国), Beijing democracy activist, under tight surveillance and restriction on movements 4. Che Hongnian (车宏年), Jinan human rights activist, under tight surveillance and restriction on movements 5. Chen Fengxiao (陈奉孝), Beijing author, under surveillance and restriction on movements, unable to leave the countryi 6. Chen Guangcheng (陈光诚), Shandong human rights defender, under soft detention at his home 7. Chen Kaige (陈凯歌), Beijing director, current situation unknown 8. Chen Mingxian (陈明先), wife of detained Sichuan democracy activist Liu Xianbin (刘 贤斌), under tight surveillance and restriction on movements, unable to leave the country 9. Chen Wei (陈卫), Sichuan human rights activist, under tight surveillance and restriction on movements , unable to leave the country 10. Chen Xi (陈西), Guizhou human rights activist, under tight surveillance and restriction on movements, unable to travel 11. Chen Yongmiao (陈永苗), Beijing internet writer, under surveillance and restriction on movements 12.
    [Show full text]
  • The Organic Chemistry of Drug Synthesis
    The Organic Chemistry of Drug Synthesis VOLUME 2 DANIEL LEDNICER Mead Johnson and Company Evansville, Indiana LESTER A. MITSCHER The University of Kansas School of Pharmacy Department of Medicinal Chemistry Lawrence, Kansas A WILEY-INTERSCIENCE PUBLICATION JOHN WILEY AND SONS, New York • Chichester • Brisbane • Toronto Copyright © 1980 by John Wiley & Sons, Inc. All rights reserved. Published simultaneously in Canada. Reproduction or translation of any part of this work beyond that permitted by Sections 107 or 108 of the 1976 United States Copyright Act without the permission of the copyright owner is unlawful. Requests for permission or further information should be addressed to the Permissions Department, John Wiley & Sons, Inc. Library of Congress Cataloging in Publication Data: Lednicer, Daniel, 1929- The organic chemistry of drug synthesis. "A Wiley-lnterscience publication." 1. Chemistry, Medical and pharmaceutical. 2. Drugs. 3. Chemistry, Organic. I. Mitscher, Lester A., joint author. II. Title. RS421 .L423 615M 91 76-28387 ISBN 0-471-04392-3 Printed in the United States of America 10 987654321 It is our pleasure again to dedicate a book to our helpmeets: Beryle and Betty. "Has it ever occurred to you that medicinal chemists are just like compulsive gamblers: the next compound will be the real winner." R. L. Clark at the 16th National Medicinal Chemistry Symposium, June, 1978. vii Preface The reception accorded "Organic Chemistry of Drug Synthesis11 seems to us to indicate widespread interest in the organic chemistry involved in the search for new pharmaceutical agents. We are only too aware of the fact that the book deals with a limited segment of the field; the earlier volume cannot be considered either comprehensive or completely up to date.
    [Show full text]
  • Wang, Prefinal3.Indd
    creators of an emperor aihe wang Creators of an Emperor: The Political Group behind the Founding of the Han Empire he enthronement of Liu Bang Ꮵ߶ initiated China’s first lasting em- T pire, the Han ዧ (206 bc–220 ad), and created a model of emperor- ship for over two millennia of subsequent dynasties. Han emperorship was a mode of Chinese authoritarianism different from the extremism of the Qin, and Liu Bang’s shadow can be recognized in many later monarchs, from Zhu Yuanzhang to Mao Zedong.1 The founding of the Han was achieved by a large group of people, addressed at the time -who sup ”,۝פ and in subsequent history as “Meritorious Officials ported Liu Bang in the civil war and enthroned him as the emperor. This group was, in essence, responsible for founding the Han dynasty and instituting its particular model of emperorship. To understand the formation of the Han dynasty, and more importantly, of the political culture that breeded authoritarianism, we need to understand the na- ture of this political group and its members’ divergent interests in pro- moting emperorship. Rather than focusing on the position of the group in the institu- tions of the empire, I study the participants’ own understandings and interpretations of the process of creating an emperor. My focus is not so much on the facts of events, as much as on how events were under- stood and interpreted by the participants and subsequent writers of the time. In other words, I want to bring to the analytical foreground the multitude of thoughts and words that motivated the actions and con- structed the events involved in creating an emperor, since it is through both words and deeds that we can allocate responsibility among those who created monarchy.2 To do so, I investigate three specific ques- This article was completed with the support of a research grant from the University of Hong Kong.
    [Show full text]
  • 66.OBARISIAGBON Aiwaguore Johnbull, AIREMWEN Collins
    Human Journals Research Article July 2020 Vol.:18, Issue:4 © All rights are reserved by OBARISIAGBON Aiwaguore Johnbull et al. Effect on Drug Release Characteristics of the Inclusion of Hydrophobic Excipients in the Formulation of Metronidazole Tablet by Melt Granulation Keywords: Metronidazole, Hydrophobic excipient, Carnauba wax, Melt granulation, Controlled release ABSTRACT OBARISIAGBON1* Aiwaguore Johnbull, Melt granulation is the process whereby the drug powder is AIREMWEN2 Collins Ovenseri mixed with melted wax, and it has been used to modify the dissolution characteristics of the drug particles. This study investigated the effect of the inclusion of hydrophobic 1. Department of Pharmaceutics/Pharmaceutical excipients (magnesium stearate or talc powder) in the Technology, College of Pharmacy, formulation of metronidazole tablets and to see their effects on the release patterns of the drug. The hydrophobic excipient Igbinedion University, Okada, Edo State, Nigeria powder was mixed with the drug (metronidazole) powder and melt granulated with Carnauba wax. The content of the wax 2. Department of Pharmaceutics/ Pharmaceutical was constant, while the hydrophobic excipient was varied from 0, 6.25, 12.5, 31.25, and 43.75 to 50% w/w respectively. The Technology, Faculty of Pharmacy, conventional granules of metronidazole were formed by wet University of Benin, Benin City, Edo State, Nigeria granulation using 20% w/v starch mucilage, screened and dried. The granules of the different formulations were then compressed in a Single Punch Tableting Machine (Manesty, Submission: 26 June 2020 England) at 4kg and tablet weight of 320 mg to obtain 250 mg Accepted: 02 July 2020 metronidazole. The tablets were subjected to disintegration time and dissolution tests respectively.
    [Show full text]
  • Dean's List Australia
    THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Australia Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Fofanah, Osman Ngunnawal 2913 Wilson, Emma Rose Jilakin 6365 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 1 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Bahamas Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Campbell, Caronique Leandra Nassau Ferguson, Daniel Nassau SP-61 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 2 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Belgium Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Lallemand, Martin Victor D Orp Le Grand 1350 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 3 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Brazil Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Rodrigues Franklin, Ana Beatriz Rio De Janeiro 22241 Marotta Gudme, Erik Rio De Janeiro 22460 Paczko Bozko Cecchini, Gabriela Porto Alegre 91340 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 4 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Canada Data as of June 15, 2020 Sorted by Zip Code, City and Last Name City State Zip Student Name (Last, First, Middle) Beijing
    [Show full text]
  • China COI Compilation-March 2014
    China COI Compilation March 2014 ACCORD is co-funded by the European Refugee Fund, UNHCR and the Ministry of the Interior, Austria. Commissioned by the United Nations High Commissioner for Refugees, Division of International Protection. UNHCR is not responsible for, nor does it endorse, its content. Any views expressed are solely those of the author. ACCORD - Austrian Centre for Country of Origin & Asylum Research and Documentation China COI Compilation March 2014 This COI compilation does not cover the Special Administrative Regions of Hong Kong and Macau, nor does it cover Taiwan. The decision to exclude Hong Kong, Macau and Taiwan was made on the basis of practical considerations; no inferences should be drawn from this decision regarding the status of Hong Kong, Macau or Taiwan. This report serves the specific purpose of collating legally relevant information on conditions in countries of origin pertinent to the assessment of claims for asylum. It is not intended to be a general report on human rights conditions. The report is prepared on the basis of publicly available information, studies and commentaries within a specified time frame. All sources are cited and fully referenced. This report is not, and does not purport to be, either exhaustive with regard to conditions in the country surveyed, or conclusive as to the merits of any particular claim to refugee status or asylum. Every effort has been made to compile information from reliable sources; users should refer to the full text of documents cited and assess the credibility, relevance and timeliness of source material with reference to the specific research concerns arising from individual applications.
    [Show full text]
  • UNIVERSITY of CALIFORNIA Santa Barbara Scribes in Early Imperial
    UNIVERSITY OF CALIFORNIA Santa Barbara Scribes in Early Imperial China A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in History by Tsang Wing Ma Committee in charge: Professor Anthony J. Barbieri-Low, Chair Professor Luke S. Roberts Professor John W. I. Lee September 2017 The dissertation of Tsang Wing Ma is approved. ____________________________________________ Luke S. Roberts ____________________________________________ John W. I. Lee ____________________________________________ Anthony J. Barbieri-Low, Committee Chair July 2017 Scribes in Early Imperial China Copyright © 2017 by Tsang Wing Ma iii ACKNOWLEDGEMENTS I wish to thank Professor Anthony J. Barbieri-Low, my advisor at the University of California, Santa Barbara, for his patience, encouragement, and teaching over the past five years. I also thank my dissertation committees Professors Luke S. Roberts and John W. I. Lee for their comments on my dissertation and their help over the years; Professors Xiaowei Zheng and Xiaobin Ji for their encouragement. In Hong Kong, I thank my former advisor Professor Ming Chiu Lai at The Chinese University of Hong Kong for his continuing support over the past fifteen years; Professor Hung-lam Chu at The Hong Kong Polytechnic University for being a scholar model to me. I am also grateful to Dr. Kwok Fan Chu for his kindness and encouragement. In the United States, at conferences and workshops, I benefited from interacting with scholars in the field of early China. I especially thank Professors Robin D. S. Yates, Enno Giele, and Charles Sanft for their comments on my research. Although pursuing our PhD degree in different universities in the United States, my friends Kwok Leong Tang and Shiuon Chu were always able to provide useful suggestions on various matters.
    [Show full text]
  • Xi Jinping's Inner Circle (Part 2: Friends from Xi's Formative Years)
    Xi Jinping’s Inner Circle (Part 2: Friends from Xi’s Formative Years) Cheng Li The dominance of Jiang Zemin’s political allies in the current Politburo Standing Committee has enabled Xi Jinping, who is a protégé of Jiang, to pursue an ambitious reform agenda during his first term. The effectiveness of Xi’s policies and the political legacy of his leadership, however, will depend significantly on the political positioning of Xi’s own protégés, both now and during his second term. The second article in this series examines Xi’s longtime friends—the political confidants Xi met during his formative years, and to whom he has remained close over the past several decades. For Xi, these friends are more trustworthy than political allies whose bonds with Xi were built primarily on shared factional association. Some of these confidants will likely play crucial roles in helping Xi handle the daunting challenges of the future (and may already be helping him now). An analysis of Xi’s most trusted associates will not only identify some of the rising stars in the next round of leadership turnover in China, but will also help characterize the political orientation and worldview of the influential figures in Xi’s most trusted inner circle. “Who are our enemies? Who are our friends?” In the early years of the Chinese Communist movement, Mao Zedong considered this “a question of first importance for the revolution.” 1 This question may be even more consequential today, for Xi Jinping, China’s new top leader, than at any other time in the past three decades.
    [Show full text]
  • Popular Protest in China: Playing by the Rules
    Popular Protest in China: Playing by the Rules The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Perry, Elizabeth J. 2010. Popular Protest in China: Playing by the Rules. In China Today, China Tomorrow: Domestic Politics, Economy and Society, ed. Joseph Fewsmith. Lanham, MD: Rowman & Littlefield. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:30827732 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#OAP <ct>Popular Protest in China: Playing by the Rules</ct> <ca>Elizabeth J. Perry</ca> Among the many surprises of the post-Mao era has been the remarkable upsurge in popular protests that has accompanied the economic reforms. The Tiananmen Uprising of 1989 was the largest and most dramatic of these incidents, but it marked neither the beginning nor the end of widespread unrest in the reform period. In the first decade of reform, China experienced a steady stream of collective protests, culminating in the massive demonstrations in Tiananmen Square (and many other Chinese cities) in the spring of 1989.1 Despite the brutal suppression of the Tiananmen Uprising, the frequency of protests has escalated in the years since June Fourth. According to official Chinese statistics, public disturbances in China increased tenfold during the period from 1993 to 2005, from 8,700 to 87,000.2 Most observers believe that the actual figures are considerably higher than these official statistics—which the Chinese government ceased making public after 2005—would suggest.
    [Show full text]
  • Recent Advances in the Discovery of Novel Antiprotozoal Agents
    molecules Review Recent Advances in the Discovery of Novel Antiprotozoal Agents Seong-Min Lee y, Min-Sun Kim y, Faisal Hayat and Dongyun Shin * College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea; [email protected] (S.-M.L.); [email protected] (M.-S.K.); [email protected] (F.H.) * Correspondence: [email protected] Authors contributed equally to this work. y Received: 3 October 2019; Accepted: 23 October 2019; Published: 28 October 2019 Abstract: Parasitic diseases have serious health, social, and economic impacts, especially in the tropical regions of the world. Diseases caused by protozoan parasites are responsible for considerable mortality and morbidity, affecting more than 500 million people worldwide. Globally, the burden of protozoan diseases is increasing and is been exacerbated because of a lack of effective medication due to the drug resistance and toxicity of current antiprotozoal agents. These limitations have prompted many researchers to search for new drugs against protozoan parasites. In this review, we have compiled the latest information (2012–2017) on the structures and pharmacological activities of newly developed organic compounds against five major protozoan diseases, giardiasis, leishmaniasis, malaria, trichomoniasis, and trypanosomiasis, with the aim of showing recent advances in the discovery of new antiprotozoal drugs. Keywords: protozoan diseases; parasitic; giardiasis; leishmaniasis; malaria; trichomoniasis; trypanosomiasis 1. Introduction It is well known that parasitic diseases are a serious health problem, that has a deep impact on the global human population [1]. Among parasites, protozoan parasites, such as Trypanosoma cruzi, Leishmania mexicana, Plasmodium falciparum, Giardia intestinalis, and Trichomonas vaginalis, are the major disease-causing organisms.
    [Show full text]